Literature DB >> 2989634

Caffeine tolerance: behavioral, electrophysiological and neurochemical evidence.

D T Chou, S Khan, J Forde, K R Hirsh.   

Abstract

The development of tolerance to the stimulatory action of caffeine upon mesencephalic reticular neurons and upon spontaneous locomotor activity was evaluated in rats after two weeks of chronic exposure to low doses of caffeine (5-10 mg/kg/day via their drinking water). These doses are achievable through dietary intake of caffeine-containing beverages in man. Concomitant measurement of [3H]-CHA binding in the mesencephalic reticular formation was also carried out in order to explore the neurochemical basis of the development of tolerance. Caffeine, 2.5 mg/kg i.v., markedly increased the firing rate of reticular neurons in caffeine naive rats but failed to modify the neuronal activity in a group exposed chronically to low doses of caffeine. In addition, in spontaneous locomotor activity studies, our data show a distinct shift to the right of the caffeine dose-response curve in caffeine pretreated rats. These results clearly indicate that tolerance develops to the stimulatory action of caffeine upon the reticular formation at the single neuronal activity level as well as upon spontaneous locomotor activity. Furthermore, in chronically caffeine exposed rats, an increase in the number of binding sites for [3H]-CHA was observed in reticular formation membranes without any change in receptor affinity. We propose, therefore, that up-regulation of adenosine receptors may underlie the development of tolerance to the CNS effects of caffeine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989634     DOI: 10.1016/0024-3205(85)90325-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Chronic caffeine treatment reduces caffeine but not adenosine effects on cortical acetylcholine release.

Authors:  R Corradetti; F Pedata; G Pepeu; M G Vannucchi
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

2.  Caffeine withdrawal affects central adenosine receptors but not benzodiazepine receptors.

Authors:  J P Boulenger; P J Marangos
Journal:  J Neural Transm Gen Sect       Date:  1989

Review 3.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

4.  A comparison of the effects of caffeine following abstinence and normal caffeine use.

Authors:  Merideth A Addicott; Paul J Laurienti
Journal:  Psychopharmacology (Berl)       Date:  2009-09-24       Impact factor: 4.530

Review 5.  Caffeine physical dependence: a review of human and laboratory animal studies.

Authors:  R R Griffiths; P P Woodson
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Multiple components of the A1 adenosine receptor-adenylate cyclase system are regulated in rat cerebral cortex by chronic caffeine ingestion.

Authors:  V Ramkumar; J R Bumgarner; K A Jacobson; G L Stiles
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

7.  Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity.

Authors:  I B Finn; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Caffeine enhances the stimulant effect of methamphetamine, but may not affect induction of methamphetamine sensitization of ambulation in mice.

Authors:  H Kuribara
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

9.  Locomotor activity in mice during chronic treatment with caffeine and withdrawal.

Authors:  O Nikodijević; K A Jacobson; J W Daly
Journal:  Pharmacol Biochem Behav       Date:  1993-01       Impact factor: 3.533

10.  Time course of tolerance to the performance benefits of caffeine.

Authors:  Beatriz Lara; Carlos Ruiz-Moreno; Juan José Salinero; Juan Del Coso
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.